What this record means
The record shows a live, pending application for the mark CONCERTO owned by Medtronic, Inc., a Minnesota corporation, and it is not yet a registration. The filing covers Class 010 medical devices used in cardiac resynchronization and heart‑failure treatment—specifically implantable defibrillators, implantable pulse generators, and their structural components—so a similar name used for any of those devices would raise the closest record‑based concern. The record does not give Medtronic control over every use of the word “CONCERTO” in other industries or product categories. This is a Principal Register application; the prosecution history shows the USPTO approved it for publication, it was published for opposition on May 12 2026, and a Notice of Allowance was issued on July 7 2026, now requiring a Statement of Use or extension within six months. The supplied history contains no oppositions, cancellations or court actions, so no enforcement signal appears. I'd treat this as a meaningful concern if you plan to market cardiac‑related devices under a similar name.
Informational only - not legal advice.